Every 8-K that Value Line Inc (VALU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow VALU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VALU filings page.
Value Line, Inc. reported that long-time director Alfred R. Fiore, who had served on the board since 2010, died on December 6, 2025. To fill the vacancy, on January 16, 2026 the board appointed Dr. Alexander J. Swistel as a director and member of the Audit Committee.
Dr. Swistel is a retired Associate Professor at Weill Cornell Medical College and a graduate of Harvard University and Brown University School of Medicine. He has no family relationships with current directors or executive officers, no material related-party transactions requiring disclosure, and will receive the standard Audit Committee director’s fee of $40,000 per year.
Value Line, Inc. held its annual shareholder meeting on October 7, 2025 to elect directors. Final tabulation by the transfer agent shows the reported Votes Yes totals for the slate of director nominees as: 9,039,480, 8,926,607, 9,070,280, 9,069,374, 435,441, and 9,033,209. The report is limited to the vote counts; no additional details about abstentions, broker non-votes, vote percentages or director identities beyond the company signature are provided.